
Canada · Semiconductors startup
Redlen Technologies Inc.
Funding reportedLast round: Series B
Follow Redlen Technologies Inc. and see its new rounds in your feed.Start following
Redlen Technologies Inc.
is a Canadian manufacturer and developer of high-resolution semiconductor radiation detectors and imaging modules, focusing on Cadmium Zinc Telluride (CZT) crystal growth technology. Founded in 1999 in Victoria, British Columbia, Redlen has become a leader in producing CZT semiconductor wafers known for their exceptional purity and uniformity, essential for advanced X-ray and gamma radiation imaging. The company operates as a wholly-owned subsidiary of Canon Inc. since its acquisition in September 2021. Redlen specializes in the development and manufacturing of CZT-based radiation detection systems. Its services include CZT crystal growth, wafer processing, detector module fabrication, and custom engineering solutions. The company offers a range of products, including photon-counting CT detector modules and high-resolution CZT radiation detector modules, which are utilized in medical imaging, security screening, and industrial applications. Redlen's proprietary Traveling Heater Method (THM) enables scalable production of high-quality CZT wafers, enhancing the performance and accessibility of radiation detection technologies across various sectors.
Funding, as reported
From Redlen Technologies Inc.'s own website: 10 on the team.
What they build
Known for
molecular breast gamma imaginghardwarehealth caresecuritygamma radiation detectionai-based imagingsemiconductor manufacturingmanufacturinghigh contrast-to-noise ratiospectral discriminationgamma radiationimaging modulesradiation imaginglow energy noise reductionsecurity screeningvolume manufacturing of czt sensors
Built with from their website
DockerGraphyAtlassianHomesteadWolters Kluwer PassportGoogle CloudPositSiemens PROFIBUSGemViewport Meta
PostgreSQLVarnishwebpack.NETGoogle Cloud HostingAIAct!Etch
Add your raise, your deck and your story, and put Redlen Technologies Inc. in front of investors. Or tell us what we have wrong.